ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,796Medicare Part D Prescriptions Filled, Including Refills

Rank: 183 out of 670

$599K Total Retail Price of All Prescriptions

Rank: 138 out of 670

517 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 517 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 6,394 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
SIMVASTATIN 465 360 1 4
LEVOTHYROXINE SODIUM 456 366 2 2
OMEPRAZOLE 341 258 3 5
LISINOPRIL 238 168 4 3
HYDROCODONE-ACETAMINOPHEN 237 137 S3 5 1
AMLODIPINE BESYLATE 213 182 6 7
METOPROLOL TARTRATE 205 182 7 9
FLUTICASONE PROPIONATE 202 142 8 37
FUROSEMIDE 189 130 9 6
GABAPENTIN 182 100 10 11
ZOLPIDEM TARTRATE 177 126 11 23
NEXIUM 175 127 12 14
ATORVASTATIN CALCIUM 164 141 13 15
METFORMIN HCL 161 118 14 8
METOPROLOL SUCCINATE 147 110 15 12
LOSARTAN POTASSIUM 120 72 16 26
ADVAIR DISKUS 120 96 16 42
HYDROCHLOROTHIAZIDE 109 69 18 10
CLOPIDOGREL 97 68 19 24
CRESTOR 92 75 20 18
CITALOPRAM HBR 88 54 21 20
WARFARIN SODIUM 84 84 22 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 71 23 27
BENICAR HCT 79 54 24 190
CARVEDILOL 78 51 25 29
PRAVASTATIN SODIUM 72 51 26 19
PLAVIX 70 58 27 34
GLIMEPIRIDE 70 57 27 32
ATENOLOL 67 43 29 17
SYNTHROID 65 59 30 47
IBUPROFEN 60 16 31 50
LOSARTAN-HYDROCHLOROTHIAZIDE 60 56 31 73
PROAIR HFA 59 29 33 28
RANITIDINE HCL 58 37 34 25
TRAMADOL HCL 57 19 35 21
LORAZEPAM 55 48 36 171
LOVAZA 54 31 37 108
SERTRALINE HCL 54 50 37 22
PANTOPRAZOLE SODIUM 54 47 37 41
DICLOFENAC SODIUM 52 44 40 110
CYCLOBENZAPRINE HCL 52 24 R 40 61
CYMBALTA 50 14 42 36
POTASSIUM CHLORIDE 50 33 42 16
SINGULAIR 50 38 42 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 26, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.